Brevan Howard Capital Management’s Vaxcyte PCVX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.79M	Buy	+54,995	New	+$1.79M	0.01%	706
2025 Q1	–	Sell	-4,393	Closed	-$360K	–	1335
2024 Q4	$360K	Buy	4,393 +2,546	+138%	+$208K	﹤0.01%	695
2024 Q3	$211K	Buy	+1,847	New	+$211K	﹤0.01%	924